Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutics and Clinical Risk Management|September 5, 2014
Emerging treatments in type 2 diabetes: focus on canagliflozinMarek Rosiak, Susanna Grzeszczak, Dariusz A Kosior, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 23, 2016
The prevalence of superior vena cava anomalies as detected in cardiac implantable electronic device recipients at a tertiary cardiology centre over a 12-year periodRoman Steckiewicz, Dariusz A Kosior, Marek Rosiak, et al.
Medycyna Pracy|May 18, 2017
[Radiographic implications of procedures involving cardiac implantable electronic devices (CIEDs) - Selected aspects]Roman Steckiewicz, Dariusz Artur Kosior, Elżbieta Barbara Świętoń, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|October 9, 2016
Reversible complete atrioventricular block in patient with wegener's granulomatosis - a report on fortunate outcome with long term follow-upRoman Steckiewicz, Marek Rosiak, Przemysław Stolarz, et al.
Kardiologia Polska|September 26, 2013
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetesAgnieszka Kapłon-Cieślicka, Marek Rosiak, Marek Postuła, et al.
Cardiology Journal|October 9, 2012
Do statins influence platelet reactivity on acetylsalicylic acid therapy in patients with type 2 diabetes?Marek Postula, Marek Rosiak, Agnieszka Kaplon-Cieslicka, et al.
Polskie Archiwum Medycyny Wewnetrznej|May 16, 2015
Association of adipokines and inflammatory markers with lipid control in type 2 diabetesAgnieszka Kapłon-Cieślicka, Marek Postuła, Marek Rosiak, et al.
Polish Archives of Internal Medicine|August 17, 2018
Functional status with rhythm- versus rate-control strategy for persistent atrial fibrillationDariusz A Kosior, Marcin Szulc, Marek Rosiak, et al.
Pageof 3